ertapeneem

Ertapenem is a carbapenem antibiotic used to treat a variety of bacterial infections. It is administered intravenously or intramuscularly. Ertapenem works by inhibiting bacterial cell wall synthesis, a mechanism common to all beta-lactam antibiotics. It is effective against a broad spectrum of Gram-positive and Gram-negative bacteria, including many anaerobic organisms.

The primary indication for ertapenem is for the treatment of moderate to severe intra-abdominal infections, skin and skin structure infections, community-acquired pneumonia, and urinary tract infections. It is also used in the treatment of certain types of pelvic inflammatory disease. Ertapenem is often reserved for situations where other antibiotics may not be effective or when resistance is a concern.

Common side effects associated with ertapenem include diarrhea, nausea, vomiting, and injection site reactions. More serious side effects are rare but can include Clostridium difficile-associated diarrhea, allergic reactions, and seizures. Ertapenem should be used with caution in patients with a history of seizures or known hypersensitivity to other beta-lactam antibiotics.

The emergence of antibiotic resistance is a significant concern with all antimicrobial agents, including ertapenem. Prudent use and adherence to prescribing guidelines are essential to preserve its efficacy. Ertapenem is available under various brand names, including Invanz.